The monkeypox virus has spread to over 75 countries, including India, infecting over 16,000 people globally. The World Health Organization has termed it a global health emergency

Ever since Moderna and Pfizer-BioNTech have started the variant-specific vaccine’s clinical trials, the international community of researchers and scientists are arguing about the necessity, need or sustainability of such variant-specific vaccines

Vaccines by the Chinese firms Sinopharm and Sinovac are being administered across the world on terms far more favorable than those of US and UK-based pharma giants

India has to scale up testing, isolating and sequencing along with vaccination and decentralized critical care to face large-scale future outbreaks, say experts

Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the possibilities and potential of the 5 candidates for the COVID-19 vaccine.

Prabir Purkayastha talks to Dr. Satyajit Rath on the concerns raised by scientists regarding COVID-19 being airborne. They also talk about why India’s strict lockdown failed to meet it goals